EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Modeling Autism Spectrum Disorders with Induced Pluripotent Stem Cell-Derived Brain Organoids

John Lenon de Souza Santos iD, Cecília de Almeida Araújo, Clarissa Araújo Gurgel Rocha iD, Zaquer Suzana Munhoz Costa-Ferro, Bruno Solano de Freitas Souza

Biomolecules · 30.01.2023 · 13 (2) · 260

DOI: 10.3390/biom13020260 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 30.01.2023. Verfasst von John Lenon de Souza Santos und 4 weiteren Autor:innen. Beteiligte Einrichtung: Gonçalo Moniz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Salvador 40296-710, Brazil. Hauptthemen laut MEDLINE: Autism Spectrum Disorder, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação Maria Emília, CNPq, CAPES.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autism spectrum disorders (ASD) are a group of complex neurodevelopmental disorders that affect communication and social interactions and present with restricted interests and repetitive behavior patterns. The susceptibility to ASD is strongly influenced by genetic/heritable factors; however, there is still a large gap in understanding the cellular and molecular mechanisms underlying the neurobiology of ASD. Significant progress has been made in identifying ASD risk genes and the possible convergent pathways regulated by these gene networks during development. The breakthrough of cellular reprogramming technology has allowed the generation of induced pluripotent stem cells (iPSCs) from individuals with syndromic and idiopathic ASD, providing patient-specific cell models for mechanistic studies. In the past decade, protocols for developing brain organoids from these cells have been established, leading to significant advances in the in vitro reproducibility of the early steps of human brain development. Here, we reviewed the most relevant literature regarding the application of brain organoids to the study of ASD, providing the current state of the art, and discussing the impact of such models on the field, limitations, and opportunities for future development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autism Spectrum DisorderInduced Pluripotent Stem CellsHumansReproducibility of ResultsBrainOrganoids

Stichwörter der Autor:innen

autism spectrum disorderbrain organoidspluripotent stem cell

Autor:innen und Institutionen

  • Gonçalo Moniz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Salvador 40296-710, Brazil.
  • Center for Biotechnology and Cell Therapy, São Rafael Hospital, Salvador 41253-190, Brazil.
  • D'Or Institute for Research and Education (IDOR), Salvador 41253-190, Brazil.

ORCID-Profile: John Lenon de Souza Santos, Clarissa Araújo Gurgel Rocha

Förderung

  • Fundação Maria Emília
  • CNPq
  • CAPES

Zitieren

APA

Santos, J. L. S., Araújo, C. A., Rocha, C. A. G., Costa-Ferro, Z. S. M., & Souza, B. S. F. (2023). Modeling Autism Spectrum Disorders with Induced Pluripotent Stem Cell-Derived Brain Organoids. Biomolecules, 13(2), 260. https://doi.org/10.3390/biom13020260

Vancouver

Santos JLS, Araújo CA, Rocha CAG, Costa-Ferro ZSM, Souza BSF. Modeling Autism Spectrum Disorders with Induced Pluripotent Stem Cell-Derived Brain Organoids. Biomolecules. 2023;13(2):260. doi:10.3390/biom13020260

BibTeX
@article{Santos2023,
  author = {Santos, John Lenon de Souza and Araújo, Cecília de Almeida and Rocha, Clarissa Araújo Gurgel and Costa-Ferro, Zaquer Suzana Munhoz and Souza, Bruno Solano de Freitas},
  title = {Modeling Autism Spectrum Disorders with Induced Pluripotent Stem Cell-Derived Brain Organoids},
  journal = {Biomolecules},
  year = {2023},
  volume = {13},
  number = {2},
  pages = {260},
  doi = {10.3390/biom13020260}
}
Kostenlos starten →